Zacks Investment Research on MSN

Medtronic Receives FDA Nod for Altaviva Device: Stock to Gain?

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...

Medtronic's New Implant Could Transform Bladder Control Treatment

Medtronic's Altaviva wins FDA approval as a minimally invasive implant for urge urinary incontinence, offering long-lasting ...

A Fresh Look at Medtronic (MDT) Valuation After FDA Green Light for Altaviva Neuromodulation Device

Medtronic (MDT) just grabbed headlines with FDA approval for its Altaviva device, a minimally invasive implantable treatment ...

Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced today that it has received U.S. Food and Drug Administration (FDA) approval for the Altaviva™ device. The minimally ...
Medical Device Network on MSN

FDA approves Medtronic’s urinary incontinence treatment device

Implantation of the device is minimally invasive, requiring no sedation or imaging, and is conducted near the ankle.
Fierce Biotech

Medtronic scores FDA approval for ankle implant to treat urinary incontinence

Medtronic has received FDA approval for a new implant aimed at improving bladder control, with a small device placed near the ...
MassDevice

Medtronic gets FDA nod for implantable neuromod for urinary incontinence

Patients who receive an Altaviva device return home with therapy activated. Medtronic says this marks a first among ...

Medtronic plc: Medtronic secures FDA approval for the Altaviva device, a simple experience for treating urge urinary incontinence

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY ...